RE1 Antibody

Shipped with Ice Packs
In Stock

Description

Definition and Target of RE1 Antibody

The RE1 antibody targets the RE1-silencing transcription factor (REST), a zinc finger protein critical for repressing neuronal genes in non-neuronal tissues and regulating chromatin remodeling . REST binds to the neuron-restrictive silencer element (NRSE/RE1) to suppress transcription of neuronal genes during development and in adult cells . RE1 antibodies are widely used to study REST’s role in neurogenesis, epigenetic regulation, and disease mechanisms such as neuropathic pain and ischemic brain injury .

Chromatin Remodeling and Gene Repression

RE1 antibodies enabled genome-wide profiling of REST-bound loci, revealing its role in modulating histone acetylation (H3K9ac, H4K8ac) and methylation (H3K4me, H3K27me3) at RE1/NRSE sites . In human T cells, REST recruitment correlates with nucleosome repositioning and transcriptional silencing of neuronal genes .

Neuropathic Pain Mechanisms

In rodent models, RE1 antibodies identified REST upregulation in dorsal root ganglion (DRG) neurons post-nerve injury. REST represses Chrm2 (muscarinic acetylcholine receptor M2) via an RE1 site, contributing to chronic pain . Knockdown of REST restored Chrm2 expression and alleviated pain .

Ischemic Brain Injury

Hippocampal REST peaks unique to human brain tissue were mapped using ChIP-seq with RE1 antibodies. These peaks associate with immune-related genes (e.g., Alox5, C1qa), linking REST to neuroinflammation post-ischemia . Inhibition of REST reduced neuronal death in ischemic models .

Cancer and Autophagy

RE1 antibodies detected REST’s interaction with β-TrCP1/2 in autophagy regulation. In pancreatic cancer, REST inactivation via ALKBH5-mediated demethylation suppressed tumor progression through PTEN/AKT signaling .

Technical Considerations

  • Western Blotting: Discrepancies in observed molecular weight (121 kDa predicted vs. 200 kDa observed) are attributed to REST’s post-translational modifications .

  • ChIP Protocols: Use cross-linking buffers optimized for REST’s nuclear localization. Proteintech’s 22242-1-AP antibody validated for ChIP in neuronal and cancer cells .

  • Storage: Most RE1 antibodies require storage at -20°C in glycerol-based buffers to prevent aggregation .

Clinical and Therapeutic Implications

  • Neurodegeneration: REST loss correlates with tauopathy and synaptic dysfunction in Alzheimer’s models .

  • Cancer: REST silencing via CRISPR or antibodies inhibits small-cell lung cancer growth by reactivating neuronal tumor suppressors .

  • Cardioprotection: REST deficiency exacerbates cardiac hypertrophy, highlighting its role in stress response .

Product Specs

Buffer
Preservative: 0.03% Proclin 300; Constituents: 50% Glycerol, 0.01M Phosphate-Buffered Saline (PBS), pH 7.4
Form
Liquid
Lead Time
14-16 week lead time (made-to-order)
Synonyms
RE1 antibody; RF12 antibody; RF28 antibody; At1g58889 antibody; R18I; antibody; RE1 antibody; At1g59265 antibody; T4M14.18 antibody; Retrovirus-related Pol polyprotein from transposon RE1 antibody; Retro element 1 antibody; AtRE1) [Includes: Protease RE1 antibody; EC 3.4.23.-); Reverse transcriptase RE1 antibody; EC 2.7.7.49); Endonuclease RE1] antibody
Target Names
RE1
Uniprot No.

Q&A

What is RE1 and what role does it play in gene regulation?

RE1 (Repressor Element 1) is a 21 bp DNA element that serves as a binding site for the REST transcription factor. REST (also known as neuron-restrictive silencing factor or NRSF) functions primarily as a transcriptional repressor that silences neuronal gene expression in non-neuronal cells . The Kruppel-type zinc finger domain of REST specifically recognizes the RE1 motif, allowing for targeted gene regulation . This interaction forms the foundation of REST's role as a system-wide transcription repressor in vertebrate neuronal development .

The RE1/REST system regulates more than 30 neuronal genes and is implicated in diverse biological processes including neurodevelopment, neurodegenerative diseases, stroke, epilepsy, cardiomyopathies, and cancer . This versatility demonstrates the profound context-specificity of REST's functional repertoire.

How can I distinguish between canonical and non-canonical RE1 sites?

Canonical RE1 sites conform closely to the consensus 21 bp motif recognized by the REST zinc finger domain. Non-canonical sites may contain variations but still retain sufficient affinity for REST binding. According to research findings, the outcomes of REST binding to canonical and non-canonical RE1 sites are nearly identical in terms of histone modifications .

For identification purposes, several probabilistic models (position specific frequency matrices or PSFMs) have been independently developed by different research groups to characterize RE1 nucleotide composition . While high-affinity RE1s can be identified by any of these models, they show differences in recognizing functional but low-affinity RE1s that may contain one or two mismatches to genuine RE1 motifs .

Methodologically, researchers should:

  • Use multiple bioinformatics tools that incorporate different RE1 motif models

  • Validate binding experimentally through ChIP assays

  • Consider the genomic context of potential RE1 sites, as non-functional RE1 mimic sites are especially enriched in repetitive sequences of human and mouse genomes

What validation strategies should I use for RE1/REST antibodies?

When validating RE1/REST antibodies for research applications, employ these methodological approaches:

  • Positive and negative control cell lines: Use cell types with known high REST expression (e.g., non-neuronal cells) versus low expression (e.g., mature neurons)

  • Knockdown verification: Perform siRNA/shRNA-mediated REST knockdown to confirm antibody specificity

  • Peptide competition assays: Pre-incubate antibody with immunizing peptide to block specific binding

  • Multiple antibody comparison: Use antibodies targeting different epitopes of REST to verify consistent results

  • Western blot analysis: Confirm single band at expected molecular weight (~200 kDa for full-length REST)

  • Immunoprecipitation followed by mass spectrometry: Ultimate verification of target specificity

Successful antibody validation should show clear enrichment at known RE1 sites (e.g., SCG10, type II sodium channel, and synapsin I genes mentioned in the literature ) when used in ChIP applications.

How do RE1/REST-mediated histone modifications correlate with gene expression?

REST binding to RE1 sites initiates a complex pattern of histone modifications that correlate with transcriptional repression. ChIP-Seq analysis has revealed a systematic decline of histone acetylations modulated by RE1/REST association . Contrastingly, histone methylations show heterogeneous changes, with some increasing (H3K27me3, H3K9me2/3) and others decreasing (H3K4me, H3K9me1) .

Importantly, these trends of histone modifications persist even in upregulated genes, demonstrating that these changes are directly RE1/REST dependent rather than determined by gene expression levels . This suggests a primary role for REST in establishing specific epigenetic landscapes regardless of transcriptional outcomes.

The correlation between REST-mediated histone modifications and RE1 motif characteristics has been experimentally established. Research data confirms that these modifications correlate with both the affinity of RE1 motifs and the abundance of RE1-bound REST molecules . This relationship provides valuable insights for experimental design when studying gene-specific effects.

What methodological approaches are optimal for studying RE1/REST chromatin interactions?

For studying RE1/REST chromatin interactions, high-throughput genome-wide approaches have provided the most comprehensive insights. The literature indicates several proven methodologies:

  • ChIP-Seq: Chromatin immunoprecipitation coupled with high-throughput sequencing, allowing genome-wide identification of REST binding sites

  • ChIP-PET: Paired-end tags approach to ChIP that provides additional positional information

  • SACO: Serial analysis of chromatin occupancy for quantitative analysis of REST binding

These approaches have revealed that REST can induce context-specific nucleosome repositioning, representing the first direct evidence of this mechanism . When designing such experiments, consider:

  • Using antibodies targeting different domains of REST to capture potential isoform-specific interactions

  • Including histone modification ChIPs in parallel to correlate REST binding with epigenetic changes

  • Incorporating nucleosome positioning assays to detect REST-induced chromatin remodeling effects

  • Analyzing multiple cell types to capture context-specific REST functions

How can I effectively analyze low-affinity RE1 sites in my research?

Low-affinity RE1 sites present unique challenges but are potentially significant in evolutionary and functional contexts. Research suggests they may serve as a genomic reservoir for the evolution of novel RE1 functional sites . To effectively study these sites:

  • Bioinformatic identification:

    • Use less stringent matrix similarity thresholds in your motif searches

    • Apply multiple RE1 position specific frequency matrices to capture different motif variants

    • Consider phylogenetic conservation to prioritize functionally relevant sites

  • Experimental verification:

    • Employ more sensitive ChIP protocols with optimized crosslinking conditions

    • Use quantitative techniques like ChIP-qPCR to detect potentially weaker REST binding

    • Consider reporter assays with mutational analysis to verify functional impact

  • Data interpretation:

    • Compare binding patterns across cell types, as context-dependent factors may enhance binding to low-affinity sites

    • Correlate with local chromatin structure data

    • Analyze evolutionary conservation patterns of potential low-affinity sites

What are the key considerations for RE1/REST ChIP experimental design?

When designing ChIP experiments to study RE1/REST interactions, several methodological factors should be considered:

  • Crosslinking optimization: REST interactions with chromatin may require different formaldehyde concentration and time than typical transcription factors

  • Sonication parameters: Optimize fragment size to 200-300 bp for precise RE1 site mapping

  • Antibody selection: Choose antibodies validated specifically for ChIP applications, targeting conserved domains of REST

  • Control regions: Include known high-affinity RE1 sites (positive controls) and regions lacking RE1 motifs (negative controls)

  • Input normalization: Carefully prepare input controls to account for chromatin accessibility differences

  • Sequential ChIP: Consider sequential ChIP (ChIP-reChIP) to investigate REST co-occupancy with other factors

The literature documents that REST binding to RE1 sites has been characterized genome-wide using various ChIP approaches coupled with high-throughput sequencing , demonstrating the feasibility of these methods for comprehensive binding site identification.

How should I approach histone modification analysis at RE1 sites?

Based on research data showing systematic RE1/REST-mediated changes in histone modifications, consider these methodological approaches:

  • Comprehensive modification profiling: Investigate diverse histone modifications as research shows REST affects at least 38 different histone modifications

  • Temporal dynamics: Design time-course experiments to capture the sequence of epigenetic events following REST binding

  • Spatial analysis: Examine modification patterns at various distances from RE1 sites to understand spreading effects

  • Cell-type comparisons: Compare patterns across cell types with different REST expression levels

  • Combinatorial modification analysis: Look for specific combinations of histone marks that correlate with different functional outcomes

Research has shown that REST induces context-specific nucleosome repositioning , suggesting that analysis of nucleosome occupancy should be incorporated alongside histone modification studies. The data indicates a complex interplay between histone modifications and nucleosome positioning that likely contributes to the versatility of REST-mediated gene regulation.

What strategies can resolve contradictory RE1/REST binding data?

When confronted with contradictory data regarding RE1/REST binding patterns or functions, consider these methodological approaches:

  • Cell-type specificity: REST function shows profound context-specificity across different biological processes , so differences between cell types should be expected and systematically investigated

  • Isoform-specific effects: Use antibodies that can distinguish between full-length REST and truncated isoforms

  • Binding co-factors: Investigate potential co-factors that might modify REST function in specific contexts

  • Integration of multiple data types: Combine ChIP-Seq, RNA-Seq, and functional assays to build a more complete picture

  • RE1 site characteristics: Analyze whether contradictions correlate with RE1 motif strength, as REST-mediated histone modifications correlate with RE1 motif affinity and REST binding abundance

The dual role of REST as both tumor suppressor and oncogene demonstrates its context-dependent function and underscores the importance of comprehensive experimental design when studying seemingly contradictory effects.

How do I analyze genome-wide RE1/REST binding patterns?

For robust analysis of genome-wide RE1/REST binding patterns, consider this structured approach:

  • Peak identification and quality control:

    • Use multiple peak callers (e.g., MACS2, GEM) to identify consistent binding regions

    • Apply stringent quality filters based on enrichment over input

    • Perform irreproducible discovery rate (IDR) analysis on replicates

  • Motif analysis:

    • Perform de novo motif discovery on peaks to verify RE1 enrichment

    • Use established RE1 position specific frequency matrices to identify canonical and non-canonical sites

    • Compare motif quality scores with binding strength

  • Genomic context analysis:

    • Annotate peaks relative to gene features (promoters, enhancers, gene bodies)

    • Analyze enrichment in specific repeat elements (human endogenous retroviruses, L2 elements)

    • Correlate with chromatin state maps (active, repressed, bivalent regions)

  • Integration with epigenomic data:

    • Align with histone modification data, focusing on modifications known to be affected by REST

    • Analyze nucleosome positioning relative to RE1 sites

    • Correlate with chromatin accessibility data (DNase-seq, ATAC-seq)

What are the best approaches for correlating REST binding with gene regulation?

To effectively correlate REST binding with gene regulation outcomes, implement these analytical strategies:

  • Integrated genomics approach:

    • Combine REST ChIP-Seq with RNA-Seq from the same biological conditions

    • Perform differential expression analysis after REST perturbation (knockdown/overexpression)

    • Correlate expression changes with REST binding strength at regulatory regions

  • Epigenetic correlation analysis:

    • Examine the relationship between REST-induced histone modification patterns and gene expression

    • Analyze how different combinations of modifications correlate with expression outcomes

    • Consider the demonstrated REST-dependent changes in histone acetylations and methylations

  • Context-specific analysis:

    • Stratify genes based on cellular context or function

    • Analyze REST binding patterns in neuronal versus non-neuronal genes

    • Investigate binding patterns in disease-relevant gene sets, considering REST's roles in various disease states

  • Temporal dynamics:

    • Design time-course experiments to capture sequential events

    • Analyze the order of REST binding, histone modification changes, and expression changes

    • Consider mathematical modeling approaches to understand the kinetics of regulation

How can emerging technologies enhance RE1/REST research?

Recent technological advances provide new opportunities for studying RE1/REST biology:

  • Single-cell approaches:

    • Single-cell ChIP-Seq to capture cell-to-cell variability in REST binding

    • Single-cell RNA-Seq to correlate with expression heterogeneity

    • Spatial transcriptomics to map REST activity in tissue contexts

  • Live-cell imaging techniques:

    • CRISPR-based imaging of RE1 loci

    • Fluorescent tagging of REST to monitor binding dynamics

    • FRAP (Fluorescence Recovery After Photobleaching) to study REST binding kinetics

  • Proteomics integration:

    • IP-Mass Spectrometry to identify REST cofactors in different contexts

    • Proximity labeling techniques to map the REST interactome

    • Cross-linking Mass Spectrometry to define REST-DNA interaction surfaces

  • Functional genomics:

    • CRISPR interference/activation at RE1 sites

    • High-throughput reporter assays to functionally characterize RE1 variants

    • Massively parallel enhancer assays to study context-dependent REST functions

What computational methods are most effective for RE1 motif analysis?

For comprehensive RE1 motif analysis and REST binding prediction, these computational approaches are recommended:

  • Advanced motif modeling:

    • Position weight matrices with nucleotide dependencies

    • Hidden Markov Models for RE1 site prediction

    • Deep learning approaches trained on ChIP-Seq data

  • Comparative genomics:

    • Cross-species conservation analysis of RE1 sites

    • Evolutionary trajectory analysis of RE1 motifs, considering their presence in repetitive elements

    • Analysis of selection pressure on functional versus non-functional RE1 sites

  • Structural biology integration:

    • Molecular modeling of REST-RE1 interactions

    • Prediction of DNA shape features that influence REST binding

    • Integration of DNase footprinting data for high-resolution binding site mapping

  • Network analysis:

    • Construction of REST-centered gene regulatory networks

    • Analysis of REST co-factors and their influence on target selectivity

    • Integration with epigenetic network models

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.